Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Linda Cook

Concepts (214)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
16
2025
205
2.750
Why?
Ovarian Neoplasms
14
2024
604
2.130
Why?
Neoplasms, Glandular and Epithelial
4
2016
52
1.160
Why?
Biomarkers, Tumor
9
2024
1339
1.010
Why?
Contraceptives, Oral, Combined
2
2016
18
0.890
Why?
Triple Negative Breast Neoplasms
5
2026
220
0.880
Why?
Breast Neoplasms
10
2025
2418
0.880
Why?
Sex Hormone-Binding Globulin
1
2019
51
0.600
Why?
Birth Order
2
2016
15
0.590
Why?
Alberta
9
2025
25
0.590
Why?
Gonadal Steroid Hormones
1
2019
143
0.550
Why?
Carcinoma, Endometrioid
4
2024
49
0.520
Why?
Immunohistochemistry
8
2024
1712
0.510
Why?
Case-Control Studies
13
2025
3647
0.490
Why?
Bone Neoplasms
3
2026
272
0.470
Why?
Alcohol Drinking
3
2024
850
0.430
Why?
Colorectal Neoplasms
2
2022
874
0.410
Why?
Risk Factors
21
2025
10921
0.390
Why?
Female
48
2026
79499
0.360
Why?
Canada
4
2019
432
0.360
Why?
Aged
25
2026
26432
0.340
Why?
Contraception
1
2013
170
0.340
Why?
Parity
4
2025
113
0.340
Why?
Receptors, Progesterone
5
2026
242
0.330
Why?
Cancer Survivors
4
2024
348
0.320
Why?
Middle Aged
27
2026
36619
0.320
Why?
Neoplasms, Cystic, Mucinous, and Serous
2
2020
27
0.310
Why?
Humans
51
2026
146342
0.280
Why?
SEER Program
2
2022
233
0.270
Why?
Receptors, Estrogen
4
2026
406
0.270
Why?
Social Support
2
2023
646
0.260
Why?
Adult
20
2026
41087
0.250
Why?
Contraceptives, Oral
3
2025
37
0.250
Why?
Adenocarcinoma, Mucinous
2
2019
76
0.240
Why?
Menopause, Premature
2
2024
12
0.230
Why?
Diphosphonates
1
2026
68
0.230
Why?
Bone Density Conservation Agents
1
2026
83
0.230
Why?
Miners
1
2025
3
0.220
Why?
Mosaicism
2
2016
67
0.220
Why?
Body Mass Index
4
2025
2458
0.220
Why?
British Columbia
4
2020
27
0.220
Why?
Prospective Studies
9
2024
8123
0.210
Why?
PAX2 Transcription Factor
1
2024
8
0.210
Why?
Cohort Studies
7
2026
6077
0.200
Why?
Neoplasms, Second Primary
1
2024
103
0.200
Why?
Tissue Array Analysis
2
2020
49
0.190
Why?
Point-of-Care Systems
1
2025
185
0.180
Why?
Workplace
1
2025
268
0.180
Why?
Cystadenocarcinoma, Serous
1
2023
90
0.180
Why?
Genital Neoplasms, Female
1
2024
100
0.180
Why?
Young Adult
9
2025
14330
0.180
Why?
Bronchitis, Chronic
1
2022
16
0.180
Why?
Sterilization, Tubal
2
2024
17
0.180
Why?
Dogs
1
2023
517
0.180
Why?
Genetic Predisposition to Disease
5
2021
2488
0.170
Why?
Neoplasm Recurrence, Local
2
2026
1160
0.170
Why?
Cigarette Smoking
1
2023
103
0.170
Why?
Proportional Hazards Models
5
2026
1331
0.170
Why?
Horticultural Therapy
1
2021
1
0.170
Why?
Neoplasm Grading
2
2020
313
0.170
Why?
DNA Mutational Analysis
2
2020
410
0.170
Why?
Menopause
3
2024
328
0.170
Why?
DNA Mismatch Repair
1
2021
54
0.170
Why?
Gardening
1
2021
13
0.170
Why?
Risk
3
2019
920
0.170
Why?
Logistic Models
3
2024
2126
0.170
Why?
Odds Ratio
5
2025
1077
0.170
Why?
Genome-Wide Association Study
4
2016
1537
0.170
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2021
42
0.170
Why?
Early Detection of Cancer
1
2026
506
0.160
Why?
New Mexico
2
2021
106
0.160
Why?
Cyclin E
1
2020
23
0.160
Why?
Vegetables
1
2021
159
0.160
Why?
Socioeconomic Factors
2
2022
1327
0.150
Why?
Washington
2
2020
157
0.150
Why?
Oncogene Proteins
1
2020
61
0.150
Why?
Pregnancy
4
2020
7230
0.150
Why?
Gene Amplification
1
2020
116
0.150
Why?
Social Class
1
2022
260
0.150
Why?
Rural Population
1
2025
677
0.150
Why?
Keratin-7
1
2019
3
0.150
Why?
Matrix Attachment Region Binding Proteins
1
2019
6
0.150
Why?
Mentors
1
2021
217
0.140
Why?
Gene Expression Regulation, Neoplastic
3
2020
1432
0.140
Why?
Carcinoma
1
2020
225
0.140
Why?
Emotions
1
2023
559
0.140
Why?
Age Factors
3
2025
3347
0.130
Why?
Lung Diseases
1
2024
787
0.130
Why?
Obesity
3
2023
3131
0.130
Why?
Ovary
1
2019
236
0.130
Why?
Surveys and Questionnaires
4
2023
6073
0.130
Why?
Observer Variation
3
2024
356
0.130
Why?
Coffee
1
2016
16
0.120
Why?
Tea
1
2016
17
0.120
Why?
X Chromosome Inactivation
1
2016
25
0.120
Why?
Tumor Suppressor Protein p53
1
2020
530
0.120
Why?
Beverages
1
2016
67
0.120
Why?
Algorithms
2
2026
1849
0.120
Why?
Caffeine
1
2016
77
0.120
Why?
Chromosomes, Human, X
1
2016
76
0.120
Why?
Guideline Adherence
1
2020
594
0.120
Why?
Neoplasms, Complex and Mixed
1
2015
7
0.120
Why?
Reproducibility of Results
5
2024
3416
0.110
Why?
United States
5
2026
16136
0.110
Why?
Glycemic Load
1
2015
2
0.110
Why?
Diet
1
2023
1273
0.110
Why?
Chromosome Aberrations
1
2015
167
0.100
Why?
Pulmonary Disease, Chronic Obstructive
1
2022
928
0.100
Why?
Incidence
2
2023
2936
0.100
Why?
Predictive Value of Tests
4
2021
2113
0.100
Why?
Quality of Life
2
2023
3200
0.100
Why?
Registries
2
2020
2400
0.100
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
32
0.100
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2013
54
0.100
Why?
Interleukin-1alpha
1
2013
55
0.100
Why?
Membrane Glycoproteins
1
2016
495
0.100
Why?
Diagnosis, Differential
3
2024
1503
0.100
Why?
Insulin Resistance
1
2022
1247
0.100
Why?
Breast Feeding
1
2017
447
0.100
Why?
Smoking
3
2025
1486
0.100
Why?
Exome
1
2014
233
0.090
Why?
Population Surveillance
1
2016
481
0.090
Why?
Breast
1
2013
155
0.090
Why?
Hypertension
1
2021
1272
0.090
Why?
Genome, Human
1
2015
431
0.090
Why?
Neoplasms
2
2026
2954
0.090
Why?
Health Services Accessibility
1
2020
1107
0.090
Why?
BRCA2 Protein
2
2023
69
0.090
Why?
BRCA1 Protein
2
2023
84
0.090
Why?
Postmenopause
1
2013
394
0.080
Why?
Insulin-Like Growth Factor I
1
2013
320
0.080
Why?
Practice Guidelines as Topic
1
2019
1591
0.080
Why?
Overweight
1
2016
614
0.080
Why?
Transcription Factors
1
2019
1730
0.080
Why?
Comorbidity
1
2016
1665
0.080
Why?
Aged, 80 and over
3
2024
8391
0.080
Why?
NF-kappa B
1
2013
674
0.080
Why?
Prevalence
3
2024
2861
0.080
Why?
Hypoglycemic Agents
1
2019
1412
0.070
Why?
Mutation
1
2020
4093
0.070
Why?
Lung Neoplasms
1
2022
2675
0.070
Why?
Vitamin D
2
2025
402
0.060
Why?
Premenopause
2
2019
130
0.060
Why?
National Cancer Institute (U.S.)
1
2026
56
0.060
Why?
Signal Transduction
2
2024
5246
0.060
Why?
Aging
1
2016
1996
0.050
Why?
Diabetes Mellitus, Type 2
1
2019
2623
0.050
Why?
Randomized Controlled Trials as Topic
2
2026
1763
0.050
Why?
Menarche
1
2025
53
0.050
Why?
Carbonyl Reductase (NADPH)
1
2024
5
0.050
Why?
Wnt4 Protein
1
2024
19
0.050
Why?
Neurofibromin 1
1
2023
26
0.050
Why?
Animals
2
2023
38106
0.050
Why?
Estrogen Replacement Therapy
1
2024
144
0.050
Why?
Hormone Replacement Therapy
1
2024
107
0.050
Why?
Polymorphism, Single Nucleotide
3
2016
2240
0.050
Why?
AMP-Activated Protein Kinases
1
2024
193
0.050
Why?
Survival Analysis
2
2016
1378
0.040
Why?
Waist-Hip Ratio
1
2022
37
0.040
Why?
Feasibility Studies
1
2026
1135
0.040
Why?
Ligands
1
2024
678
0.040
Why?
Waist Circumference
1
2022
142
0.040
Why?
Smokers
1
2022
139
0.040
Why?
Healthy Lifestyle
1
2021
38
0.040
Why?
Forced Expiratory Volume
1
2022
451
0.040
Why?
ROC Curve
1
2023
617
0.040
Why?
Risk Assessment
2
2020
3712
0.040
Why?
Phenotype
2
2021
3206
0.040
Why?
Genotype
2
2016
1879
0.040
Why?
Adiponectin
1
2022
243
0.040
Why?
Data Collection
1
2023
650
0.040
Why?
Dyspnea
1
2022
251
0.040
Why?
In Situ Hybridization
1
2020
317
0.040
Why?
North America
1
2020
300
0.040
Why?
Australia
1
2020
291
0.040
Why?
Kaplan-Meier Estimate
1
2022
970
0.040
Why?
Appendiceal Neoplasms
1
2019
28
0.040
Why?
United Kingdom
1
2020
377
0.040
Why?
Germ-Line Mutation
1
2020
180
0.040
Why?
Retrospective Studies
3
2024
17438
0.040
Why?
Gene Expression Profiling
2
2015
1792
0.030
Why?
Pregnancy Outcome
1
2020
503
0.030
Why?
Antihypertensive Agents
1
2021
519
0.030
Why?
Adenocarcinoma
1
2024
927
0.030
Why?
Neoplasm Metastasis
1
2019
693
0.030
Why?
Connecticut
1
2016
25
0.030
Why?
Diabetes Mellitus
1
2025
1101
0.030
Why?
Chromosomes, Human, Pair 6
1
2016
51
0.030
Why?
Physician-Patient Relations
1
2020
597
0.030
Why?
Pilot Projects
1
2021
1888
0.030
Why?
Risk Reduction Behavior
1
2017
220
0.030
Why?
Women's Health
1
2017
317
0.030
Why?
Europe
1
2015
421
0.030
Why?
Neoplasm Invasiveness
1
2016
504
0.030
Why?
Sensitivity and Specificity
1
2019
1998
0.030
Why?
Global Health
1
2017
403
0.030
Why?
Up-Regulation
1
2016
841
0.020
Why?
Polymerase Chain Reaction
1
2016
1031
0.020
Why?
Gene Frequency
1
2014
496
0.020
Why?
Male
4
2025
73396
0.020
Why?
Biopsy
1
2015
1075
0.020
Why?
Mammography
1
2013
175
0.020
Why?
Genetic Association Studies
1
2013
379
0.020
Why?
Prognosis
1
2020
4351
0.020
Why?
DNA Methylation
1
2016
725
0.020
Why?
Biomarkers
1
2022
4340
0.020
Why?
Inflammation
1
2022
2919
0.020
Why?
Cross-Sectional Studies
1
2022
5899
0.020
Why?
Exercise
1
2021
2213
0.020
Why?
Lung
1
2022
4122
0.020
Why?
Research Design
1
2015
1143
0.020
Why?
Genetic Variation
1
2014
996
0.020
Why?
Cytokines
1
2015
2081
0.020
Why?
Longitudinal Studies
1
2013
3017
0.010
Why?
Cook's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)